Cable Viewer

Currently released so far... 12476 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/06
1986/05
1987/06
1988/01
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/06 1992/12
1993/10
1996/11
1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ASEC AF AFIN AM AJ AG AS AEMR AMGT AORC APER AU ACBAQ AFGHANISTAN AR AE ADANA ADPM APECO AMED AX AL ADCO AA AECL AADP AMEX ACAO ANET AODE ASCH AY APEC AID AORG ASEAN ABUD AGAO AFSI AFSN AINF AGR AROC AO AFFAIRS ASIG ABLD ASUP AND ARM AQ ATFN AC ATRN ACOA AMBASSADOR AUC ASEX ARF APCS AER AVERY AGRICULTURE AMG AORL AGMT ALOW AFU ASECKFRDCVISKIRFPHUMSMIGEG AZ AN AMCHAMS AIT ADM ACABQ ACS
BR BK BA BRUSSELS BEXP BM BD BL BO BU BILAT BN BT BX BTIO BIDEN BG BE BP BY BBSR BC BTIU BWC BB BF BH BMGT
CO CASC CS CA CONDOLEEZZA CE CVIS CU CPAS CMGT COUNTER CH COUNTRY CJAN CG CIDA CJUS CI CY CD CDG CBSA CEUDA CR CM CLMT CAC CBW CODEL COPUOS CIC CW CBE CHR CFED CT CONS CWC CIA CTM CDC CVR CF CLINTON COUNTERTERRORISM CITEL CLEARANCE COE CN CACS CAN CB CSW CITT CARSON CACM CDB COM CROS CV CAPC CKGR CBC CTR CNARC CARICOM CL CICTE CIS
DR DHS DA DJ DEA DPRK DEPT DOMESTIC DOE DS DE DEFENSE DO DAO DCM DEAX DK DTRA DISENGAGEMENT DOD
EINV ETRD ECON EPET ENRG EAGR EC EFIN EAID ELTN EIND ELAB EAIR ECIN EUN EG EU ETTC ET EI EWWT EFIS EMIN ER EPA ENVI ENGR ETRC EXTERNAL ECPS EN ELN EINT ETRDEINVTINTCS ES EZ ETRO ETRDEINVECINPGOVCS EDU ETRN EFTA EAIG EK EUREM ECONCS ECONOMICS ENVR ELECTIONS EAP ENIV ECONOMY ESA EINN ECONOMIC EIAR EXBS ECA ECUN EINDETRD EUR EREL EUC ESENV ECONEFIN ECIP ENERG EFIM EAIDS ETRDECONWTOCS EUNCH EINVETC EURN EINVEFIN ETC ENGY EINVECONSENVCSJA EUMEM ETRA ERD ENNP ECINECONCS EFINECONCS EEPET EXIM ERNG
FR FREEDOM FTA FJ FARC FI FTAA FAC FBI FOREIGN FOI FM FAO FAS FINR FDA FOR FINANCE FMLN FO FISO
GTMO GG GM GV GOV GOI GL GAERC GH GA GY GT GR GF GCC GE GZ GTIP GERARD GLOBAL GANGS GAZA
HO HA HR HUMAN HK HU HILLARY HI HSTC HURI HYMPSK HUMOR HEBRON
IR IAEA IS IZ IN IT IO IAHRC ID IC IRAQI IWC ISLAMISTS IV ICAO INDO ITPHUM ITPGOV ITALIAN IPR ICRC INTERPOL IQ IBET IMO INR INTERNAL ICJ ICTY IRS ILO INRA INRO ISRAELI IEA INRB ITALY IL ITU ITRA IBRD IIP ILC IZPREL IMF IRAJ IA IDP ITF IF INMARSAT INTELSAT IGAD ISRAEL ICTR IEFIN IRC IACI IDA
JA JO JUS JP JOSEPH JM JAMES JOHNNIE JOHN
KS KN KTFN KTDB KTIP KIRF KPAO KDEM KCOR KE KMPI KSCA KZ KG KNUP KNNP KPAL KCRM KIPR KPKO KFLO KSEP KOMC KISL KNNPMNUC KWBG KFRD KUNR KWMN KSTC KFLU KOLY KMDR KJUS KSTH KAWC KU KWAC KNPP KERG KSEO KACT KHLS KGHG KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KCRCM KDRG KTIA KVPR KV KIDE KICC KPRP KBIO KSUM KGIT KCFE KBTS KCIP KGIC KPAI KTLA KTEX KFSC KPLS KHIV KCSY KSAC KTRD KID KMRS KOM KSAF KRVC KR KMOC KNAR KHDP KSPR KFIN KBTR KOCI KJUST KNEI KAWK KGCC KMCA KBCT KREL KMFO KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KFTFN KVRP KIRC KCOM KO KLIG KAID KNSD KHUM KSEC KRAD KCMR KPWR KCHG KICA KPIN KESS KDEV KCGC KWWMN KPRV KPAK KWNM KWMNCS KRFD KVIR KSCI KPOA KDDG KWMM KCFC KTER KREC KIFR KCRS KHSA KRGY KMIG KTBT KOMS KX KRCM KRIM KPAONZ KNUC KDEMAF
LE LY LG LH LI LTTE LAB LOG LA LT LO LU LABOR
MP MY MOPS MCAP MARR MNUC MUCN MTCRE MASS MAPP MIL MX MEDIA MO MPOS MU ML MA MERCOSUR MG MD MW MK MAS MT MI MOPPS MASC MR MTS MLS MILI MAR MTRE MEPN MTCR MEPI MQADHAFI MAPS MARAD MEETINGS MEPP MZ MILITARY MDC MC MV MCC MRCRE MASSMNUC MIK
NU NZ NATO NPT NL NI NAFTA NDP NIPP NP NPA NG NRR NO NEW NE NH NR NA NS NSF NZUS NATIONAL NSG NC NT NAR NK NV NORAD NASA NSSP NW NATOPREL NPG NGO NSC NSFO
OVIP OPIC OEXC OTRA OPDC OREP OAS OPRC OIIP OSCE OFFICIALS OMIG ODIP OFDP OECD OBSP OPCW OTR OSAC OSCI ON OCII OES OVP OPAD OFDA OIE OIC OHUM OCS
PGOV PINR PREL PHSA PTER PE PREF PHUM PK PARM PINS PM PL PO PA PBTS PBIO POL PARMS PROG PAK POLITICS PORG PTBS PNAT PUNE POLICY PDOV PCI PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PBT PP PS PG PY PTERE PGOF PALESTINIAN PKFK PSOE PEPR PPA PINT PMAR PRELP PSEPC PREFA PGOVE PINF PNG PMIL PGOC PFOR PCUL PLN PROP PAO POLINT PGGV PHALANAGE PARTY PGOVLO PHUS PDEM PECON PROV PAS PHUMPREL PGIV PRAM PF PRL PHUH PHUMBA POV PSA PHUMPGOV POGOV PEL PNR PREO PAHO PSI PINL PU PRGOV PAIGH POLITICAL PARTIES POSTS
QA
RS RCMP RICE RU REACTION REPORT REGION RIGHTS RO RW RF RM RFE RSP RP RIGHTSPOLMIL ROBERT ROOD RELATIONS RUPREL RSO
SOCI SN SY SNAR SENV SP SZ SCUL SA SO SW SMIG SU SENVKGHG SR SYRIA SF SI SC SWE SARS STEINBERG SG SIPRS ST SL SPCE SNARIZ SSA SK SPCVIS SOFA SEVN SIPDIS SAN SYR SHUM SANC SNARCS SAARC SNARN SHI SH SEN SCRS
TU TPHY TI TX TSPL TRGY TBIO TF TERRORISM TH TIP TC TO TSPA TW TZ TNGD TT TL TV TS TRSY TINT TN TURKEY TBID TD TP TAGS TFIN TK TR THPY
UK UNSC USTR UG UNGA UZ USEU US UN UNC USUN UP UY UNESCO USPS UNHRC UNO UNHCR UNCHR USAID UNVIE UAE UNMIK USOAS UNFICYP UV UNEP UNODC UNCHS UNIDROIT UNDESCO UNCHC UNDP UNAUS USNC UNCSD UNCND UNICEF UNDC UNPUOS UE
VT VZ VE VTEG VTPREL VM VI VTIZ VAT VN VC
WS WTO WTRO WTRQ WI WZ WHO WFP WWARD WHA WB WBG WIPO WITH WMO WEU WHTI WMD WA
XA XF XM XL XW XV XR XB XU XY XH XG XE XK XX XD XI XT XS XC XZ XTAG XQ
YE YM YI YMCS
ZI ZO ZU ZEALAND ZK ZR ZF ZP ZN ZA ZB ZOELLICK ZL ZANU ZJ

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:35 | 2011-04-24 00:00 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`